Why the SARS-CoV-2 antibody test results may be misleading: insights from a longitudinal analysis of COVID-19
Taubel, J.; Cole, S. T.; Spencer, C. S.; Freier, A.; Camilleri, D.; Lorch, U.
Show abstract
To estimate the effectiveness of vaccines in development, a robust mechanism is required to understand immunity, risks of reinfection and measure the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and how this may change over time. This study is a longitudinal analysis of COVID-19 infection rates using PCR, membrane immunoassay and chemiluminescent microparticle immunoassay (CMIA) diagnostic tests. Our data confirm that antibody levels wane in the three months after symptom onset. Comparison of the three methods used suggests that quantitative CMIA testing may exaggerate numbers of COVID-19 negative individuals.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway 96%
- Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level 94%
- A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects 94%
Similar papers in this journal
- Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection 94%
- Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena Valley 94%
- Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand 93%
Similar papers in this journal
- Evaluation of six commercial SARS-CoV-2 Enzyme-Linked Immunosorbent assays for clinical testing and serosurveillance 95%
- Acceptability, usability and performance of lateral flow immunoassay tests for SARS-CoV-2 antibodies: REACT-2 study of self-testing in non-healthcare key workers 94%
- Dynamic change and clinical relevance of post-infectious SARS-CoV-2 antibody responses 94%
Similar papers in this journal
- SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali 95%
- Screening for high amounts of SARS-CoV-2 identifies pre-symptomatic subjects among healthy healthcare workers 93%
- Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccine 93%
Similar papers in this journal
- The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs 94%
- Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay 94%
- Long Term Accuracy of SARS-CoV-2 Interferon-γ Release Assay and its Application in Household Investigation 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.